How Can CPNs Revolutionize Medical Diagnostics?

In this interview conducted at MEDICA 2022, our CEO, Andy Chaloner, spoke with NewsMedical about how our Conjugated Polymer Nanoparticles could revolutionise applications in diagnostics.

12 December, 2022
The Medicine Maker: ‘The Pandemic Diaries’

In this article in The Medicine Maker, our CEO, Andy Chaloner, discusses the shift in business priorities and resulting opportunities during the COVID-19 pandemic with Stephane Argivier, CEO of MIP Diagnostics.

5 August, 2020